Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04DQF
|
||||
Former ID |
DNC007236
|
||||
Drug Name |
2-(3-acetylphenyl)-6-morpholino-4H-pyran-4-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528738] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H17NO4
|
||||
Canonical SMILES |
CC(=O)C1=CC=CC(=C1)C2=CC(=O)C=C(O2)N3CCOCC3
|
||||
InChI |
1S/C17H17NO4/c1-12(19)13-3-2-4-14(9-13)16-10-15(20)11-17(22-16)18-5-7-21-8-6-18/h2-4,9-11H,5-8H2,1H3
|
||||
InChIKey |
MUGFHNCVHGYLEQ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | DNA-dependent protein kinase catalytic subunit | Target Info | Inhibitor | [528738] | |
KEGG Pathway | Non-homologous end-joining | ||||
Cell cycle | |||||
NetPath Pathway | IL1 Signaling Pathway | ||||
Reactome | Nonhomologous End-Joining (NHEJ) | ||||
References | |||||
Ref 528738 | J Med Chem. 2007 Apr 19;50(8):1958-72. Epub 2007 Mar 20.Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase. | ||||
Ref 528738 | J Med Chem. 2007 Apr 19;50(8):1958-72. Epub 2007 Mar 20.Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.